Literature DB >> 19415429

Local therapies in migraine.

Marco Aguggia1.   

Abstract

Fixed-site" approach and "follow-the-pain" approach briefly considered the techniques of local therapy that now generate more interest and discussion on headaches and, in particular, of migraine. Far from being a full discussion, the work aims only to stimulate further thought and interest in local therapies which often are not sufficiently considered and that conversely are a possibility in the treatment of migraine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415429     DOI: 10.1007/s10072-009-0072-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  22 in total

1.  Botulinum toxin type A: myths, facts, and current research.

Authors:  Stephen D Silberstein; K Roger Aoki
Journal:  Headache       Date:  2003 Jul-Aug       Impact factor: 5.887

2.  Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.

Authors:  Paul L Durham; Ryan Cady; Roger Cady
Journal:  Headache       Date:  2004-01       Impact factor: 5.887

Review 3.  Procedures for administering botulinum toxin type A for migraine and tension-type headache.

Authors:  Andrew M Blumenfeld; William Binder; Stephen D Silberstein; Andrew Blitzer
Journal:  Headache       Date:  2003-09       Impact factor: 5.887

4.  The concept of migraine as a state of central neuronal hyperexcitability.

Authors:  K M Welch; G D'Andrea; N Tepley; G Barkley; N M Ramadan
Journal:  Neurol Clin       Date:  1990-11       Impact factor: 3.806

5.  Headache in magical and medical papyri of ancient Egypt.

Authors:  A Karenberg; C Leitz
Journal:  Cephalalgia       Date:  2001-11       Impact factor: 6.292

6.  Induction of long-lasting changes of visual cortex excitability by five daily sessions of repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers and migraine patients.

Authors:  A Fumal; G Coppola; V Bohotin; P-Y Gérardy; L Seidel; A-F Donneau; M Vandenheede; A Maertens de Noordhout; J Schoenen
Journal:  Cephalalgia       Date:  2006-02       Impact factor: 6.292

7.  Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms.

Authors:  J Purkiss; M Welch; S Doward; K Foster
Journal:  Biochem Pharmacol       Date:  2000-06-01       Impact factor: 5.858

8.  Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.

Authors:  William Young; James Shaw; Melissa Bloom; Cheryl Gebeline-Myers
Journal:  Headache       Date:  2008 Nov-Dec       Impact factor: 5.887

9.  Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases.

Authors:  Stewart J Tepper; Marcelo E Bigal; Fred D Sheftell; Alan M Rapoport
Journal:  Headache       Date:  2004-09       Impact factor: 5.887

Review 10.  Evidence for antinociceptive activity of botulinum toxin type A in pain management.

Authors:  K Roger Aoki
Journal:  Headache       Date:  2003 Jul-Aug       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.